Digital devices and artificial intelligence offer promising prospects for the early detection, monitoring, and management of cardiac arrhythmias.
Answers are grounded in this paper and cite their sources.
Supports arrhythmia monitoring in select patients; leaves open need for RCTs before routine adoption.
Developing digital devices and remote technologies for the diagnosis and management of arrhythmias are revolutionizing cardiologist clinical practice and decision-making. Electrocardiogram (ECG) and plethysmography (PPG)-based devices are widely used to assess cardiac rhythm. Artificial intelligence (AI) enabled devices may contribute to early detection and monitoring of atrial fibrillation (AF), long QT syndrome (LQTS), as well as QTc related adverse drug events. Some other devices such as contactless rhythm monitoring may be useful in ambulatory cardiac arrhythmia mass screening. Keywords Digital device ;Arrhythmia ;Atrial fibrillation ;Artificial intelligence ;Review.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: